Navigation Links
FDA Approves Novel Creation of Imitrex? Injection for Migraine

The Food and Drug Administration (FDA) has approved a creation of the Imitrex Injection that enables patients to consume a 4mg dosage, // named as the Imitrex STAT dose System ? used to treat severe migraines in adults in the presence or absence of aura.

Migraine is known to be a common ailment for as many as 28 million Americans suffers from migraine headaches. The treatments for migraines differ according to the intensity of the attack and hence vary from patient to patient. Since migraine attacks vary in its severity, it is imperative to enable patients with various treatment options.

Though oral medication is effective in certain cases, sometimes an injection might be more appropriate when the intensity of the attack is severe.

Morning migraines begin for patients as early as the waking hours when patients awaken with a moderate to severe headache. Statistics have it that an average of 48% headaches attack between 4 am and 9 am.

Migraines are also accompanied by nausea and vomiting in almost 48% of the cases. Migraines are also known to accelerate in intensity, and in such cases an injection is known to alleviate the pain.

Robert Kaniecki, MD, director of The Headache Center at the University of Pittsburgh and assistant professor of neurology, said, “ Imitrex Injection is now an effective option for patients with certain types of migraines and Migraine patients who experience nausea or vomiting with their headaches, often require an injection, since oral treatments are typically not well tolerated by these patients. Additionally, injections bypass the digestive system and enter the bloodstream quickly, which is especially important for treating certain migraine attacks, such as morning and rapidly escalating migraines.”


'"/>




Page: 1

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA Approves New HIV Drug, Viread
3. FDA Approves Birth Control Skin Patch
4. FDA Approves New Arthritis Drug, Bextra
5. FDA Approves Elidel Cream for Eczema
6. FDA Approves New Anti-Clotting Drug
7. FDA Approves New surgery Treatment for Farsightedness
8. FDA Approves Anti-Cancer Cell Drug - Zevalin
9. FDA Approves Remodulin for Pulmonary Hypertension
10. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
11. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... easier access to the robotic-assisted total-hip and partial-knee replacement surgeries that are ... at Forbes Hospital and Jefferson Hospital recently started performing these surgeries using ...
(Date:3/29/2017)... VA (PRWEB) , ... March 29, 2017 , ... ... its seventh North American office location in Richmond, Virginia, located at the Riverfront Plaza, ... 11, attended by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield Advisors is ... his extensive knowledge of appraisals, property values, ad valorem taxation, and government policy ... industry for more than 40 years. , “Ruel is a great addition to ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017   Royal ... leader in health technology, and PathAI, a company ... collaborating with the aim to develop solutions that ... of cancer and other diseases. The partnership aims ... enabling this form of artificial intelligence to be ...
(Date:3/29/2017)... 29, 2017 Neurim Pharmaceuticals ("Neurim") ... obtain exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... treat sleep disorders in children with Autism Spectrum Disorders (ASD) and ... approved for children. The collaboration with Exeltis will help ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The global patient safety and risk management software market ... Patient safety has become a priority for almost ... significantly in the last decade and is currently on the verge ...
Breaking Medicine Technology: